255 related articles for article (PubMed ID: 8186951)
21. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
[TBL] [Abstract][Full Text] [Related]
22. Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy.
Pountney DL; Dickson TC; Power JH; Vickers JC; West AJ; Gai WP
Neurotox Res; 2011 Jan; 19(1):115-22. PubMed ID: 20039155
[TBL] [Abstract][Full Text] [Related]
23. Multiple system atrophy: a review of 203 pathologically proven cases.
Wenning GK; Tison F; Ben Shlomo Y; Daniel SE; Quinn NP
Mov Disord; 1997 Mar; 12(2):133-47. PubMed ID: 9087971
[TBL] [Abstract][Full Text] [Related]
24. Microglial activation parallels system degeneration in multiple system atrophy.
Ishizawa K; Komori T; Sasaki S; Arai N; Mizutani T; Hirose T
J Neuropathol Exp Neurol; 2004 Jan; 63(1):43-52. PubMed ID: 14748560
[TBL] [Abstract][Full Text] [Related]
25. [An autopsy case of multiple system atrophy with many Lewy bodies--striatonigral degeneration, olivo-ponto-cerebellar atrophy and autonomic nerve nucleus involvement in the spinal cord].
Morioka E; Kuroda S; Kuyama K; Otsuki S; Hosokawa K; Namba R
No To Shinkei; 1987 Apr; 39(4):361-6. PubMed ID: 3036191
[TBL] [Abstract][Full Text] [Related]
26. Spatial patterns of alpha-synuclein positive glial cytoplasmic inclusions in multiple system atrophy.
Armstrong RA; Lantos PL; Cairns NJ
Mov Disord; 2004 Jan; 19(1):109-12. PubMed ID: 14743371
[TBL] [Abstract][Full Text] [Related]
27. Grading of neuropathology in multiple system atrophy: proposal for a novel scale.
Jellinger KA; Seppi K; Wenning GK
Mov Disord; 2005 Aug; 20 Suppl 12():S29-36. PubMed ID: 16092088
[TBL] [Abstract][Full Text] [Related]
28. Argentophilic intracytoplasmic inclusions in multiple system atrophy.
Mochizuki A; Mizusawa H; Ohkoshi N; Yoshizawa K; Komatsuzaki Y; Inoue K; Kanazawa I
J Neurol; 1992 Jul; 239(6):311-6. PubMed ID: 1380981
[TBL] [Abstract][Full Text] [Related]
29. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions.
Huang Y; Song YJ; Murphy K; Holton JL; Lashley T; Revesz T; Gai WP; Halliday GM
Acta Neuropathol; 2008 Dec; 116(6):639-46. PubMed ID: 18936941
[TBL] [Abstract][Full Text] [Related]
30. Differences between multiple system atrophy and olivopontocerebellar atrophy.
Quinn N; Daniel S
Ann Neurol; 1996 Dec; 40(6):945-6. PubMed ID: 9007105
[No Abstract] [Full Text] [Related]
31. Neuronal cell loss of the striatonigral system in multiple system atrophy.
Kume A; Takahashi A; Hashizume Y
J Neurol Sci; 1993 Jul; 117(1-2):33-40. PubMed ID: 8410064
[TBL] [Abstract][Full Text] [Related]
32. Striatonigral degeneration combined with olivopontocerebellar atrophy with subcortical dementia and hallucinatory state.
Fukutani Y; Takeuchi N; Kobayashi K; Miyazu K; Yamaguchi N; Terada T; Nakamura I; Isaki K
Dementia; 1995; 6(4):235-40. PubMed ID: 7550604
[TBL] [Abstract][Full Text] [Related]
33. [Multiple system atrophy (MSA)].
Moriwaka F; Tashiro K
Nihon Rinsho; 1993 Nov; 51(11):2952-6. PubMed ID: 8277576
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin-positive inclusions in different types of multiple system atrophy: distribution and specificity.
Probst-Cousin S; Bergmann M; Kuchelmeister K; Schröder R; Schmid KW
Pathol Res Pract; 1996 May; 192(5):453-61. PubMed ID: 8832750
[TBL] [Abstract][Full Text] [Related]
35. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
[TBL] [Abstract][Full Text] [Related]
36. Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy.
Nakamura S; Kawamoto Y; Nakano S; Akiguchi I; Kimura J
J Neuropathol Exp Neurol; 1998 Jul; 57(7):690-8. PubMed ID: 9690673
[TBL] [Abstract][Full Text] [Related]
37. Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course.
Masui K; Nakata Y; Fujii N; Iwaki T
Neuropathology; 2012 Feb; 32(1):69-76. PubMed ID: 21615514
[TBL] [Abstract][Full Text] [Related]
38. [MRI study of degenerative process in multiple system atrophy].
Yagishita T; Kojima S; Hirayama K
Rinsho Shinkeigaku; 1995 Feb; 35(2):126-31. PubMed ID: 7781226
[TBL] [Abstract][Full Text] [Related]
39. [Multiple system atrophy - synuclein and neuronal degeneration].
Yoshida M
Rinsho Shinkeigaku; 2011 Nov; 51(11):838-42. PubMed ID: 22277386
[TBL] [Abstract][Full Text] [Related]
40. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
